Literature DB >> 7924856

Efficacy and safety of indomethacin 0.1% versus flurbiprofen 0.03% eyedrops in inflammation after argon laser trabeculoplasty. The Belgian Study Group on Glaucoma.

M Goethals1, L Missotten.   

Abstract

After Argon Laser Trabeculoplasty (ALT), non steroidal anti-inflammatory drugs (Indomethacin 1% suspension and Flurbiprofen 0.03% solution) were shown to be efficient in the management of post laser inflammation. To evaluate the efficacy and safety of Indomethacin 0.1% solution versus Flurbiprofen 0.03% eyedrops in that purpose. 64 patients suffering from glaucoma were recruited in a multicenter randomized double masked study. The results demonstrate that Indomethacin 0.1% eyedrops is as efficient as Flurbiprofen 0.03% in terms of control of post ALT inflammation, with a good tolerance.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7924856     DOI: 10.1007/bf01664937

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  24 in total

1.  Argon laser trabeculoplasty controls one third of cases of progressive, uncontrolled, open angle glaucoma for 5 years.

Authors:  G L Spaeth; K A Baez
Journal:  Arch Ophthalmol       Date:  1992-04

Review 2.  [Argon laser trabeculoplasty].

Authors:  F Moulin
Journal:  J Fr Ophtalmol       Date:  1991       Impact factor: 0.818

3.  Long-term reduction of intraocular pressure after repeat argon laser trabeculoplasty.

Authors:  D K Grayson; C B Camras; S M Podos; J S Lustgarten
Journal:  Am J Ophthalmol       Date:  1988-09-15       Impact factor: 5.258

4.  Argon laser trabeculoplasty. Studies of mechanism of action.

Authors:  E M Van Buskirk; V Pond; R C Rosenquist; T S Acott
Journal:  Ophthalmology       Date:  1984-09       Impact factor: 12.079

5.  Laser trabeculoplasty primary therapy in open-angle glaucoma. A preliminary report.

Authors:  A R Rosenthal; P R Chaudhuri; A P Chiapella
Journal:  Arch Ophthalmol       Date:  1984-05

6.  [The technic of argon laser trabeculoplasty and its results].

Authors:  Y Kitazawa; T Yamamoto; S Shirato; S Eguchi
Journal:  Klin Monbl Augenheilkd       Date:  1984-04       Impact factor: 0.700

7.  Argon laser trabeculoplasty medical therapy to prevent the intraocular pressure rise associated with argon laser trabeculoplasty.

Authors:  A L Robin
Journal:  Ophthalmic Surg       Date:  1991-01

8.  Inflammation patterns after laser trabeculoplasty measured with the laser flare meter.

Authors:  A Mermoud; N Pittet; C P Herbort
Journal:  Arch Ophthalmol       Date:  1992-03

9.  Ten year results of laser trabeculoplasty. Does the laser avoid glaucoma surgery or merely defer it?

Authors:  J B Wise
Journal:  Eye (Lond)       Date:  1987       Impact factor: 3.775

10.  Flurbiprofen pretreatment in argon laser trabeculoplasty for primary open-angle glaucoma.

Authors:  R N Weinreb; A L Robin; G Baerveldt; M V Drake; M Blumenthal; J Wilensky
Journal:  Arch Ophthalmol       Date:  1984-11
View more
  4 in total

Review 1.  The emerging roles of topical non-steroidal anti-inflammatory agents in ophthalmology.

Authors:  P Koay
Journal:  Br J Ophthalmol       Date:  1996-05       Impact factor: 4.638

2.  Emerging roles of topical non-steroidal anti-inflammatory agents in ophthalmology.

Authors:  C Trinquand
Journal:  Br J Ophthalmol       Date:  1996-12       Impact factor: 4.638

3.  Drug-Loaded Polymeric Micelles Based on Smart Biocompatible Graft Copolymers with Potential Applications for the Treatment of Glaucoma.

Authors:  Manuela-Ramona Blanaru Ozturk; Marcel Popa; Delia Mihaela Rata; Anca Niculina Cadinoiu; Frederique Parfait; Christelle Delaite; Leonard Ionut Atanase; Carmen Solcan; Oana Maria Daraba
Journal:  Int J Mol Sci       Date:  2022-08-19       Impact factor: 6.208

Review 4.  The role of NSAIDs in the management of postoperative ophthalmic inflammation.

Authors:  Joseph Colin
Journal:  Drugs       Date:  2007       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.